Search Results for "Sk Biopharmaceuticals Korea"

19:28 EST 26th February 2015 | BioPortfolio

Matching Channels

CaptureSelect

BAC’s CaptureSelect products are affinity ligands and affinity resins created by a proprietary technology based on Camelid-derived single domain antibody fragments for the purification of biop...

Boehringer Ingelheim

Boehringer Ingelheim is a global pharmaceutical company with annual sales of over $16 billion, making it the 10th largest pharmaceutical company in the world based on sales.  With bases in 47 c...

BioPortfolio Twitter Accounts

BioPortfolio has created approx 150 Twitter accounts with currently (June 2013 - 25,000 Twitter Followers) to support our users interest in keeping upto date on the latest news, research papers, rep...

Matching News

RegeneRx links with G-treeBNT to develop RGN-259 in the USA

US biotech firm RegeneRx Biopharmaceuticals has entered into agreements with South Korea-based G-treeBNT to develop RGN-259 for dry eye syndrome and neurotrophic keratitis (an orphan indication) in t...

BASF Opens Electronics R&D Center in Korea

BASF has opened its new regional Electronic Materials R&D Center in Korea at Sungkyunkwan University's (SKKU) Suwon Campus in Gyeonggi. The new facility, the German group's first R&D base in K...

Merck Animal Health and XL-protein Partner to Produce Biopharmaceuticals for Animals

The companies partnered to create more effective biopharmaceuticals through the exploitation of PASylation. Date:  Fri, 2015-02-13 (All day) ...

EPIRUS Biopharmaceuticals hält Präsentation auf Leerink Global Healthcare Conference

EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS), ein in Boston ansässiges Biopharmaunternehmen, das sich auf die weltweite Entwicklung und Vermarktung von biosimilaren monoklonalen Antikörpern konze.....

Purple not yet the new orange: US FDA biopharmaceuticals list lacks dates

A new list of biopharmaceuticals published by the US FDA provides limited information with only the entries for Neupogen, Perjecta and Granix including expiry dates.

BRIEF-ThromboGenics says Jetrea wins approval in South Korea

* Has been approved in South Korea for treatment of adults with symptomatic vitreomacular adhesion (VMA) Further company coverage:

CPhI Korea 2014 Scheduled for Sept. 2-3

CPhI Korea trade show provides industry leaders access to the growing South Korean market.

Alder BioPharmaceuticals regains pharma licensing rights from BMS

Alder BioPharmaceuticals has regained the worldwide pharma licensing rights to clazakizumab, a humanized monoclonal antibody to the pro-inflammatory cytokine IL-6, from Bristol-Myers Squibb based on B...

Matching PubMed Articles

Mini-review: Targeted biopharmaceuticals for cancer treatment.

Cancer is a complex invasive genetic disease that causes significant mortality rate worldwide. Protein-based biopharmaceuticals have significantly extended the lives of millions of cancer patients. Th...

Biopharmaceutical discovery and production in yeast.

The selection of an expression platform for recombinant biopharmaceuticals is often centered upon suitable product titers and critical quality attributes, including post-translational modifications. A...

Cost-of-Illness Trend of Thyroid Gland Disease in Korea.

Cost-of-Illness Trends Associated with Thyroid Disease in Korea.

The purpose of this study is to analyze the scale of and trends associated with the cost-of-illness of thyroid disease in Korea at 2-year intervals during the last 10 years for which data are availabl...

Work-Related Asthma in Korea - Findings from the Korea Work-Related Asthma Surveillance (KOWAS) program, 2004-2009.

To determine the incidence and epidemiological characteristics of work-related asthma in Korea.

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement